| Date Filed | Type | Description |
| 02/11/2015 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2015 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 0% stake in AVANIR PHARMACEUTICALS INC |
| 02/09/2015 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 12.1% stake in AVANIR PHARMACEUTICALS INC |
| 01/26/2015 |
SC 13G/A
| BlackRock Inc. reports a 7.5% stake in AVANIR PHARMACEUTICALS INC |
| 01/13/2015 |
8-K
| Quarterly results |
| 01/13/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/12/2015 |
SC 13G/A
| FMR LLC reports a 2.4% stake in AVANIR PHARMACEUTICALS |
| 01/06/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/05/2015 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 12/31/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 12/12/2014 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 12/12/2014 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 12/11/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/10/2014 |
10-K
| Annual Report for the period ended September 30, 2014 |
| 12/10/2014 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 12/02/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/02/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 12/02/2014 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 12/02/2014 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 11/26/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/12/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/10/2014 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 17% stake in Avanir Pharmaceuticals, Inc. |
| 11/10/2014 |
SC 13G/A
| FMR LLC reports a 10.8% stake in AVANIR PHARMACEUTICALS |
| 11/07/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/25/2014 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 09/25/2014 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 09/22/2014 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 09/15/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/12/2014 |
SC 13G/A
| INGALLS & SNYDER LLC reports a 3.8% stake in AVANIR PHARMACEUTICALS, INC. |
| 08/06/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
| 08/05/2014 |
8-K
| Quarterly results |
| 06/10/2014 |
SC 13G
| BAKER BROS. ADVISORS LP reports a 10.8% stake in Avanir Pharmaceuticals, Inc. |
| 05/09/2014 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 05/07/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
|